The acquisition will expand Optum’s ability to help consumers improve population health and address the challenges of healthcare costs. Additionally, the agreement allows Alere to focus on strengthen its leadership in the global rapid diagnostics market and improve its balance sheet.
The acquisition takes the form of a $600 million cash transaction subject to customary regulatory approval and other closing conditions.
More articles on healthcare transactions:
Wake Forest Baptist Medical Center to partner with Omnicell
Lancaster General Health, UPenn Health System exploring stronger ties
Mercy Health System, Rockford Health System to merge
